FDA Approves Adcirca (Tadalafil) For PAH; United Therapeutics Ready For U.S. Launch
Tadalafil benefit to clinical worsening claim made it into labeling, but not into the indication.
Tadalafil benefit to clinical worsening claim made it into labeling, but not into the indication.